VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Men and women patients, with age ranging 40-80     │ Men and women patients, with age ranging 40-80     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Suspected coronary artery disease who are supposed │ Suspected coronary artery disease who are supposed │     100 │
│ to undergo invasive coronary angiography with      │ to undergo invasive coronary angiography with      │         │
│ appropriate clinical indications                   │ appropriate clinical indications                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients who are willing to sign the informed      │ Patients who are willing to sign the informed      │     100 │
│ consent form                                       │ consent form                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Contraindication of CT Known allergy to iodinated  │ Contraindication of CT Known allergy to iodinated  │     100 │
│ contrast media or history of contrast-induced      │ contrast media or history of contrast-induced      │         │
│ nephropathy Decreased renal function: elevated     │ nephropathy Decreased renal function: elevated     │         │
│ serum creatinine(\>1.5mg/dl) Contraindication to   │ serum creatinine(>1.5mg/dl) Contraindication to    │         │
│ beta-blockers Severe arrhythmia: arterial          │ beta-blockers Severe arrhythmia: arterial          │         │
│ fibrillation or uncontrolled tachyarrhythmia, or   │ fibrillation or uncontrolled tachyarrhythmia, or   │         │
│ advanced atrioventricular block (second or third   │ advanced atrioventricular block (second or third   │         │
│ degree heart block)                                │ degree heart block)                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Unstable or uncooperative patients                 │ Unstable or uncooperative patients                 │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Limited life expectancy due to cancer or end-stage │ Limited life expectancy due to cancer or end-stage │     100 │
│ renal or liver disease                             │ renal or liver disease                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Evidence of severe symptomatic heart failure (NYHA │ Evidence of severe symptomatic heart failure (NYHA │     100 │
│ Class III or IV)                                   │ Class III or IV)                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Previous myocardial infarction, coronary artery    │ Previous myocardial infarction, coronary artery    │     100 │
│ intervention, coronary artery bypass surgery, or   │ intervention, coronary artery bypass surgery, or   │         │
│ other cardiac surgery                              │ other cardiac surgery                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Contraindication of MRI Claustrophobia Metallic    │ Contraindication of MRI Claustrophobia Metallic    │      99 │
│ hazards Pacemaker implant eGFR\<30 ml/min          │ hazards Pacemaker implant eGFR<30 ml/min           │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                  │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════╪═════════╡
│ Must have maximum age of 80 Years │ Men and women patients, with age ranging 40-80 │      38 │
├───────────────────────────────────┼────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 40 Years │ Men and women patients, with age ranging 40-80 │      41 │
╘═══════════════════════════════════╧════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 88.9090909090909
OverAll Ratio: 92.95454545454545
